118 related articles for article (PubMed ID: 36697063)
1. Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway.
Sano Y; Kuwabara N; Nakagawa S; Toda Y; Hosogi S; Sato S; Ashihara E
Anticancer Res; 2023 Feb; 43(2):547-555. PubMed ID: 36697063
[TBL] [Abstract][Full Text] [Related]
2. Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.
Nerdal PT; Peters C; Oberg HH; Zlatev H; Lettau M; Quabius ES; Sousa S; Gonnermann D; Auriola S; Olive D; Määttä J; Janssen O; Kabelitz D
J Immunol; 2016 Oct; 197(8):3059-3068. PubMed ID: 27619996
[TBL] [Abstract][Full Text] [Related]
3. Expansion of human peripheral blood γδ T cells using zoledronate.
Kondo M; Izumi T; Fujieda N; Kondo A; Morishita T; Matsushita H; Kakimi K
J Vis Exp; 2011 Sep; (55):. PubMed ID: 21931292
[TBL] [Abstract][Full Text] [Related]
4. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152
[TBL] [Abstract][Full Text] [Related]
5. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
6. Targeting gamma delta T cells for cancer immunotherapy: bench to bedside.
Gogoi D; Chiplunkar SV
Indian J Med Res; 2013 Nov; 138(5):755-61. PubMed ID: 24434328
[TBL] [Abstract][Full Text] [Related]
7. Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells
Wang S; Li H; Ye C; Lin P; Li B; Zhang W; Sun L; Wang Z; Xue D; Teng W; Zhou X; Lin N; Ye Z
Front Immunol; 2018; 9():377. PubMed ID: 29535738
[TBL] [Abstract][Full Text] [Related]
8. Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism.
Gruenbacher G; Nussbaumer O; Gander H; Steiner B; Leonhartsberger N; Thurnher M
Oncoimmunology; 2014; 3(8):e953410. PubMed ID: 25960933
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma cells adapted to long-exposure of hypoxia exhibit stem cell characters with TGF-β/Smad pathway activation.
Nakagawa Y; Ashihara E; Yao H; Yokota A; Toda Y; Miura Y; Nakata S; Hirai H; Maekawa T
Biochem Biophys Res Commun; 2018 Feb; 496(2):490-496. PubMed ID: 29309790
[TBL] [Abstract][Full Text] [Related]
10. Small molecules for the activation of human gammadelta T cell responses against infection.
Kabelitz D
Recent Pat Antiinfect Drug Discov; 2008 Jan; 3(1):1-9. PubMed ID: 18221182
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis.
Laurent AJ; Bindslev N; Johansson B; Berg L
PLoS One; 2014; 9(8):e103683. PubMed ID: 25090614
[TBL] [Abstract][Full Text] [Related]
12. Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism.
Wang H; Sarikonda G; Puan KJ; Tanaka Y; Feng J; Giner JL; Cao R; Mönkkönen J; Oldfield E; Morita CT
J Immunol; 2011 Nov; 187(10):5099-113. PubMed ID: 22013129
[TBL] [Abstract][Full Text] [Related]
13. Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
Idrees AS; Sugie T; Inoue C; Murata-Hirai K; Okamura H; Morita CT; Minato N; Toi M; Tanaka Y
Cancer Sci; 2013 May; 104(5):536-42. PubMed ID: 23387443
[TBL] [Abstract][Full Text] [Related]
14. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells.
Gober HJ; Kistowska M; Angman L; Jenö P; Mori L; De Libero G
J Exp Med; 2003 Jan; 197(2):163-8. PubMed ID: 12538656
[TBL] [Abstract][Full Text] [Related]
15. In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
Burjanadzé M; Condomines M; Reme T; Quittet P; Latry P; Lugagne C; Romagne F; Morel Y; Rossi JF; Klein B; Lu ZY
Br J Haematol; 2007 Oct; 139(2):206-16. PubMed ID: 17897296
[TBL] [Abstract][Full Text] [Related]
16. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
Knight A; Mackinnon S; Lowdell MW
Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570
[TBL] [Abstract][Full Text] [Related]
17. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.
Roelofs AJ; Jauhiainen M; Mönkkönen H; Rogers MJ; Mönkkönen J; Thompson K
Br J Haematol; 2009 Jan; 144(2):245-50. PubMed ID: 19016713
[TBL] [Abstract][Full Text] [Related]
19. Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function.
Wang H; Chen H; Liu S; Zhang J; Lu H; Somasundaram R; Choi R; Zhang G; Ou L; Scholler J; Tian S; Dong L; Yeye G; Huang L; Connelly T; Li L; Huang A; Mitchell TC; Fan Y; June CH; Mills GB; Guo W; Herlyn M; Xu X
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34937742
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells.
Li J; Herold MJ; Kimmel B; Müller I; Rincon-Orozco B; Kunzmann V; Herrmann T
J Immunol; 2009 Jun; 182(12):8118-24. PubMed ID: 19494338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
